5-乙酰氨基-6-氨基-3-甲基尿嘧啶(AAMU)结构式
|
常用名 | 5-乙酰氨基-6-氨基-3-甲基尿嘧啶(AAMU) | 英文名 | N-(6-amino-3-methyl-2,4-dioxo-1H-pyrimidin-5-yl)acetamide |
|---|---|---|---|---|
| CAS号 | 19893-78-8 | 分子量 | 198.17900 | |
| 密度 | 1.45g/cm3 | 沸点 | N/A | |
| 分子式 | C7H10N4O3 | 熔点 | ≥305ºC | |
| MSDS | 中文版 美版 | 闪点 | N/A |
| 中文名 | 5-乙酰氨基-6-氨基-3-甲基尿嘧啶(AAMU) |
|---|---|
| 英文名 | N-(6-amino-3-methyl-2,4-dioxo-1H-pyrimidin-5-yl)acetamide |
| 英文别名 | 更多 |
| 密度 | 1.45g/cm3 |
|---|---|
| 熔点 | ≥305ºC |
| 分子式 | C7H10N4O3 |
| 分子量 | 198.17900 |
| 精确质量 | 198.07500 |
| PSA | 109.98000 |
| 折射率 | 1.606 |
| 个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| 危险品运输编码 | NONH for all modes of transport |
| WGK德国 | 3 |
| 海关编码 | 2933599090 |
|
~%
5-乙酰氨基-6-氨基-3-甲... 19893-78-8 |
| 文献：Roehrkasten; Raatz; Kreher; Blaszkewicz Zeitschrift fur Naturforschung - Section B Journal of Chemical Sciences, 1997 , vol. 52, # 12 p. 1526 - 1532 |
|
~%
5-乙酰氨基-6-氨基-3-甲... 19893-78-8 |
| 文献：Roehrkasten; Raatz; Kreher; Blaszkewicz Zeitschrift fur Naturforschung - Section B Journal of Chemical Sciences, 1997 , vol. 52, # 12 p. 1526 - 1532 |
|
~%
5-乙酰氨基-6-氨基-3-甲... 19893-78-8 |
| 文献：Roehrkasten; Raatz; Kreher; Blaszkewicz Zeitschrift fur Naturforschung - Section B Journal of Chemical Sciences, 1997 , vol. 52, # 12 p. 1526 - 1532 |
|
~96%
5-乙酰氨基-6-氨基-3-甲... 19893-78-8 |
| 文献：Roehrkasten; Raatz; Kreher; Blaszkewicz Zeitschrift fur Naturforschung - Section B Journal of Chemical Sciences, 1997 , vol. 52, # 12 p. 1526 - 1532 |
|
~%
5-乙酰氨基-6-氨基-3-甲... 19893-78-8 |
| 文献：Gala; DiBenedetto; Gloor; Jenkins; Kugelman; Maloney; Miller Organic Process Research and Development, 2004 , vol. 8, # 3 p. 396 - 400 |
| 5-乙酰氨基-6-氨基-3-甲基尿嘧啶(AAMU)上游产品 6 | |
|---|---|
| 5-乙酰氨基-6-氨基-3-甲基尿嘧啶(AAMU)下游产品 0 | |
| 海关编码 | 2933599090 |
|---|---|
| 中文概述 | 2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期 |
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Caffeine as a metabolic probe: validation of its use for acetylator phenotyping.
Clin. Pharmacol. Ther. 49(6) , 648-57, (1991) The use of two caffeine metabolite ratios for acetylator phenotyping was validated by demonstrating concordance with two sulfamethazine tests in 178 unrelated healthy subjects. The caffeine metabolite... |
|
|
An alternative test for acetylator phenotyping with caffeine.
Clin. Pharmacol. Ther. 42(5) , 509-13, (1987) Previously published methods allow the determination of the genetically controlled acetylator status using caffeine as a test drug, based on the urinary excretion of a ring-opened metabolite of caffei... |
|
|
Extractionless method for the simultaneous high-performance liquid chromatographic determination of urinary caffeine metabolites for N-acetyltransferase 2, cytochrome P450 1A2 and xanthine oxidase activity assessment.
J. Chromatogr. B. Biomed. Sci. Appl. 755(1-2) , 73-84, (2001) Urinary metabolic ratios of caffeine are used in humans to assess the enzymatic activities of cytochrome P450 isoenzyme 1A2 (CYP1A2), xanthine oxidase (XO) and for phenotyping individuals for the bimo... |
| Acetamide,N-(4-amino-1,2,3,6-tetrahydro-1-methyl-2,6-dioxo-5-pyrimidinyl) |
| n-(6-amino-3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)acetamide |
| 5-acetamido-6-amino-3-methyluracil |
| AAMU |
| N-(4-Amino-1,2,3,6-tetrahydro-1-methyl-2,6-dioxo-5-pyrimidinyl)acetimide |
| 5-Ammu |
| 5-Acetylamino-6-amino-3-methyluracil |
